DE HB15 | 2023-2024 | 152nd General Assembly
Status
Completed Legislative Action
Spectrum: Moderate Partisan Bill (Democrat 28-8)
Status: Passed on March 21 2024 - 100% progression
Action: 2024-03-21 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Spectrum: Moderate Partisan Bill (Democrat 28-8)
Status: Passed on March 21 2024 - 100% progression
Action: 2024-03-21 - Signed by Governor
Text: Latest bill text (Engrossed) [HTML]
Summary
This Act requires all individual, blanket, and group health insurance policies to cover annual ovarian cancer screening tests for women at risk for ovarian cancer. It further expands the scope of monitoring tests available to women subsequent to ovarian cancer treatment.
Title
An Act To Amend Title 18 Of The Delaware Code Relating To Ovarian Cancer.
Sponsors
Roll Calls
2024-03-21 - Senate - Senate Third Reading (Y: 21 N: 0 NV: 0 Abs: 0) [PASS]
2024-03-19 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
2024-03-19 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-03-21 | Signed by Governor | |
| 2024-03-21 | Passed By Senate. Votes: 21 YES | |
| 2024-03-20 | Reported Out of Committee (Health & Social Services) in Senate with 7 Favorable | |
| 2024-03-19 | Assigned to Health & Social Services Committee in Senate | |
| 2024-03-19 | Passed By House. Votes: 39 YES 2 ABSENT | |
| 2024-03-19 | Amendment HA 1 to HB 15 - Passed In House by Voice Vote | |
| 2024-03-14 | Amendment HA 1 to HB 15 - Introduced and Placed With Bill | |
| 2024-03-13 | Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits | |
| 2024-02-29 | Introduced and Assigned to Health & Human Development Committee in House |
